Glucose control in the older patient: from intensive, to effective and safe (Q37637818)

21 August 2017

1 reference

title

Glucose control in the older patient: from intensive, to effective and safe (English)

1 reference

21 August 2017

0 references

0 references

2

1 reference

21 August 2017

Ligia J Dominguez

1

1 reference

PubMed ID

19934622

21 August 2017

Mario Barbagallo

series ordinal

3

1 reference

21 August 2017

17 November 2009

1 reference

Aging Clinical and Experimental Research

21 August 2017

1 reference

21 August 2017

22

1 reference

21 August 2017

4

1 reference

21 August 2017

274-280

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03337724

21 August 2017

0 references

cites work

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Benefits and risks of tight glucose control in critically ill adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Risk of fractures with glitazones: a critical review of the evidence to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Insulin causes endothelial dysfunction in humans: sites and mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Visceral adipose tissue and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Does diabetes therapy influence the risk of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Older women with diabetes have a higher risk of falls: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

The relationship between glycemic control and falls in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

Patient-important outcomes in diabetes—time for consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03337724

21 January 2018

Identifiers

DOI

10.1007/BF03337724

1 reference

21 August 2017

1 reference

PubMed ID

19934622